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Abstract
Long noncoding RNAs (lncRNAs) have emerged as critical regulators in various cellular 
processes. However, the potential involvement of lncRNAs in kinase signaling remains largely 
unknown. AMP-activated protein kinase (AMPK) acts as a critical sensor of cellular energy status. 
Here we show that lncRNA NBR2 (neighbor of BRCA1 gene 2) is induced by the LKB1-AMPK 
pathway under energy stress. Upon energy stress, NBR2 in turn interacts with AMPK and 
promotes AMPK kinase activity, thus forming a feed-forward loop to potentiate AMPK activation 
during energy stress. Depletion of NBR2 attenuates energy stress-induced AMPK activation, 
resulting in unchecked cell cycling, altered apoptosis/autophagy response, and increased tumor 
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development in vivo. NBR2 is down-regulated and its low expression correlates with poor clinical 
outcomes in some human cancers. Together, our study uncovers a mechanism coupling lncRNAs 
with metabolic stress response, and provides a broad framework to further understand the 
regulation of kinase signaling by lncRNAs.
Introduction
Mammalian genomes encode more than 10,000 long noncoding RNAs (lncRNAs), the RNA 
molecules which are longer than 200 nucleotides and do not appear to encode proteins1, 2. 
Although lncRNAs were traditionally viewed as the products that are generated from the 
background noise of transcription and thus exert little fitness advantage to the cells, it has 
become increasingly clear that these lncRNAs play important biological functions, and their 
dysregulation has been connected to various human diseases, including cancer3–6.
Most current studies focus on lncRNA function in the nucleus, partly because most of the 
best-understood lncRNAs, such as XIST7, HOTAIR8, HOTTIP9, are all chromatin-
associated lncRNAs, which are mainly localized in the nucleus. These studies have 
illustrated a diverse range of functions of lncRNAs in the regulation of chromatin status, 
transcription, and RNA processing, among others1, 10. Many lncRNAs have also been 
identified in the cytosol11. In fact, it has been suggested that the majority of lncRNAs 
probably spend most of their life time in the cytoplasm1. However, the exact functions of 
cytoplasmic localized lncRNAs, particularly their potential functions in the regulation of 
kinase signaling in the cytoplasm, remain poorly understood. In addition, although lncRNAs 
have been shown to regulate diverse biological processes, the role of lncRNAs in mediating 
metabolic checkpoint remains largely unexplored.
The AMP-activated protein kinase (AMPK) serves as a critical sensor of cellular energy 
status and is activated under energy stress conditions with an increased cellular AMP/ATP 
ratio12. AMP binding to AMPK and subsequent AMPK phosphorylation at Thr172 by the 
upstream kinase LKB1 leads to AMPK activation13–15. Activated AMPK then 
phosphorylates a number of downstream targets to inactivate ATP-consuming anabolic 
processes and to activate ATP-generating catabolic processes16. Thus, AMPK mainly 
functions as a metabolic checkpoint to restore energy balance in response to energy stress. 
One major anabolic process inhibited by AMPK in response to energy stress is mammalian 
target of rapamycin complex 1 (mTORC1)-mediated protein synthesis and cell growth17. In 
response to energy stress, AMPK inactivates mTORC1 and represses protein synthesis via 
AMPK phosphorylation of Raptor, a component of mTORC1, and the TSC1-TSC2 complex, 
a negative regulator of mTORC118, 19. AMPK also functions to promote autophagy and cell 
survival under energy stress via its phosphorylation of autophagy regulators, such as 
ULK120, 21. As anabolic processes, such as protein and lipid synthesis, often exert pro-
growth effects in tumor development, it is well documented that AMPK activation serves to 
inhibit tumor development in many cancers22. Consistent with this, both the upstream kinase 
Lkb1 and downstream effectors of AMPK, such as TSC1 and TSC2, are bona fide tumor 
suppressors and are mutated in hamartoma tumor syndromes and various sporadic 
cancers
23
–
25
. Although the biological functions of AMPK and its downstream effectors 
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involved in cancer development have been extensively studied22, 26, the regulatory 
mechanisms of AMPK activation by energy stress remain incompletely understood. In 
particular, it remains completely unknown whether any lncRNA is involved in AMPK-
mediated metabolic checkpoint.
In this study, we identify neighbor of BRCA1 gene 2 (NBR2) as an energy stress-induced 
lncRNA and show that NBR2 interacts with AMPK and potentiates AMPK activation under 
energy stress. Consistent with the tumor suppression function of AMPK, NBR2 deficiency 
promotes unchecked cell cycling under energy stress and enhances tumor development in 
vivo, and NBR2 is down-regulated in human cancers. Our study thus reveals a previously 
unappreciated regulatory mechanism by lncRNAs to regulate kinase function and to mediate 
cellular energy responses.
Results
Energy stress induces NBR2 expression through the LKB1-AMPK pathway
To identify energy stress-induced lncRNAs, we conducted an RNA sequencing experiment 
in 786-O cells that had been cultured in glucose-containing or glucose-free medium. 
Subsequent computational analysis identified NBR2 as one of the long intergenic noncoding 
RNAs (lincRNAs) induced by glucose starvation. NBR2 gene encodes different splicing 
isoforms ranging from 1 to 2 kb (Supplemental Fig. 1). It has been shown that NBR2 is 
expressed in most of the tissues examined27. However, NBR2 gene does not appear to 
encode a protein, and its potential function remains unknown.
Real-time PCR revealed that glucose starvation induced NBR2 expression in different cancer 
cell lines, except Hela and A549 cells, which are Lkb1 deficient (Fig. 1a). Treatment with 
the glucose analog 2-deoxy-glucose (2DG), another energy stress inducer that inhibits 
hexokinase and blocks glycolysis, yielded similar results (Fig. 1b). Importantly, re-
expression of Lkb1 in these Lkb1-deficient cells restored energy stress-induced NBR2 
expression (Fig. 1c, d). In addition, treatment of A769662 (an AMPK activator) induced 
NBR2 expression (Fig. 1e), while AMPK inactivation by compound C (an AMPK inhibitor) 
treatment or siRNA-mediated AMPKα knockdown significantly attenuated glucose 
starvation-induced NBR2 expression (Fig. 1f, g, and Supplemental Fig. 2). Together, our 
results revealed that energy stress induces NBR2 expression at least partly through the 
LKB1-AMPK pathway.
NBR2 regulates AMPK-mTORC1 signaling under energy stress
To study the potential function of NBR2 in mediating energy stress response, we generated 
786-O cells (a kidney cancer cell line) and MDA-MB231 cells (a breast cancer cell line) 
with stable knockdown of NBR2 (Fig. 2a). We then analyzed whether knockdown of NBR2 
affected any biochemical signaling surrogate induced by energy stress, including AMPK 
activation. As shown in Fig. 2b, glucose starvation potently induced phosphorylation of 
AMPK, or AMPK substrates acetyl CoA carboxylase (ACC) and Raptor18, 28. Notably, 
NBR2 knockdown significantly attenuated glucose starvation-induced phosphorylation of 
AMPK, ACC and Raptor. Accordingly, S6 and S6K de-phosphorylation induced by glucose 
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deprivation was significantly compromised in NBR2 knockdown cells compared with 
control shRNA-infected cells (Fig. 2c). Finally, NBR2 knockdown also attenuated 2DG or 
A769662 treatment-induced AMPK activation and mTORC1 inactivation (Fig. 2d, e). Our 
results thus revealed that NBR2 depletion attenuates energy stress-induced AMPK activation 
and mTORC1 inactivation, and suggested a feed-forward mechanism on NBR2-AMPK 
regulation, in which AMPK initially promotes NBR2 expression in response to energy stress 
and NBR2 in turn regulates AMPK activation under energy stress (see Discussion).
NBR2 regulates cell proliferation, apoptosis, and autophagy in response to energy stress
AMPK functions as a critical metabolic checkpoint; defective AMPK signaling leads to 
increased cell proliferation yet decreased autophagy under conditions of energy stress, 
leading to apoptosis12, 20. The aforementioned data prompted us to examine the impact of 
NBR2 deficiency on cell proliferation, apoptosis, and autophagy in response to energy 
stress. Glucose starvation dramatically decreased S phase entry as measured by BrdU 
incorporation, and knockdown of NBR2 significantly attenuated the reduction of S phase 
entry upon glucose starvation (Fig. 3a–c). Thus, similar to cells with defective AMPK 
signaling18, NBR2 deficient cells continue cycling under energy stress.
Although NBR2 depletion did not affect apoptosis under normal culture condition, NBR2 
deficiency induced more apoptosis under glucose starvation, as evidenced by both Annexin 
V staining (Fig. 3d, e) and cleaved caspase-3 Western blotting (Fig 3f). In response to energy 
stress, AMPK activates autophagy, a cellular adaptive response to promote cell survival 
under stress conditions20, 21. Accordingly, glucose starvation-induced GFP-LC3 puncta 
formation, p62 degradation, and ULK1 phosphorylation were significantly compromised in 
NBR2 deficient cells (Fig. 3g, h, and Supplemental Fig. 3a, b), suggesting that energy stress-
induced autophagy was defective in NBR2 deficient cells. Despite enhanced apoptosis, the 
number in NBR2 deficient cells increased under glucose deprived conditions because of the 
increase in cycling in NBR2 deficient cells (Fig. 3i, j, and Supplemental Fig. 3c, d). 
Collectively, our results showed that NBR2 deficiency leads to enhanced cell cycling yet 
decreased autophagy and increased apoptosis under energy stress, which is in line with the 
phenotypes from cells with defective AMPK signaling, including AMPK, Lkb1, TSC1, 
TSC2 deficient cells or cells reconstituted with a Raptor mutant which is non-
phosphorylatable by AMPK15, 18, 19, 29, 30.
NBR2 inhibits tumor development and is down-regulated in human cancers
Given the important functions of AMPK in the regulation of human cancers22, we next 
examined the potential roles of NBR2 in tumor development. NBR2 deficiency led to 
increased anchorage-independent growth, one of the hallmarks of cell transformation, with a 
more prominent effect under glucose starvation conditions (Fig. 4a, b). In vivo experiments 
using the xenograft model showed that NBR2 deficiency increased tumor development (Fig. 
4c). Further analyses of the tumor samples by Western blotting confirmed down-regulation 
of AMPK and up-regulation of mTORC1 signaling in NBR2 deficient tumors (Fig. 4d).
Consistent with the experimental results from breast and renal cancer cell lines, a survey of 
the RNA-seq data across different cancer types from the TCGA (The Cancer Genome Atlas) 
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datasets revealed down-regulation of NBR2 expression in breast (BRCA) and renal (KIRC) 
cancer samples compared with paired normal tissue samples (Fig. 4e, f). Kaplan Meier 
analysis showed that breast cancer patients with NBR2-low tumors had significantly worse 
overall survival than those with NBR2-high tumors (Fig. 4g). Together, our data showed that 
NBR2 deficiency promotes tumor development, and NBR2 is down-regulated in human 
breast and renal cancers, suggesting that NBR2 may function as a tumor suppressor in these 
cancers.
Energy stress induces NBR2 interaction with AMPK
The aforementioned biological data prompted us to further study how NBR2 regulates 
AMPK function. Real-time PCR analyses of fractionated nuclear and cytoplasmic RNA 
revealed that NBR2 localized in both nucleus and cytoplasm (Fig. 5a). As expected, AMPK 
α showed predominant localization in the cytoplasm (Fig. 5b). AMPK exists as a 
heterotrimeric complex which consists of a catalytic α subunit and two regulatory β and γ 
subunits31. We thus examined whether NBR2 can interact with any of the subunits of AMPK 
by RNA-pulldown assay using in vitro-synthesized biotinylated NBR2. Such analysis 
revealed that NBR2 interacted with overexpressed AMPK α under glucose starvation 
condition, with minimal binding with overexpressed β or γ subunit (Fig. 5c). The RNA 
pulldown assay also revealed that glucose starvation significantly increased the interaction of 
NBR2 with endogenous AMPKα (Fig. 5d). Since AMPK α, β and γ subunits form a very 
stable complex at the endogenous level, we also observed a glucose starvation-induced 
binding between NBR2 and endogenous AMPK β and γ subunits (Fig. 5d), likely mediated 
by NBR2 interaction with endogenous AMPK α subunit. In vitro binding assay using 
purified AMPK α and in vitro-synthesized biotinylated NBR2 confirmed the direct binding 
between NBR2 and AMPK α (Fig. 5e). There exist at least three splicing isoforms of NBR2 
gene (named as NBR2 #1, #2 and #3, see Supplemental Fig. 1). In the RNA pulldown 
experiments described above, we utilized NBR2 #1 splicing isoform. The RNA pulldown 
experiments showed that NBR2 #2 and #3 splicing isoforms also interacted with AMPK α 
upon glucose starvation (Fig. 5f). Finally, RNA immunoprecipitation (RIP) assay (using the 
primers which can detect all three NBR2 splicing isoforms) revealed an enrichment of 
NBR2 in the precipitates of AMPK α compared with IgG control, and glucose starvation 
substantially increased the enrichment of NBR2 in AMPK α precipitates (Note that glucose 
starvation resulted in much more fold increase of NBR2 level in AMPK α precipitates than 
of NBR2 input level) (Fig. 5g).
In the experiment to map the region(s) of AMPK α which mediates AMPK interaction with 
NBR2, we showed that kinase domain-containing N terminal region, but not the C terminal 
region of AMPK α, interacted with NBR2 (Fig. 5h). Mutation of threonine 172 to alanine in 
AMPK α did not affect AMPK α interaction with NBR2 (Fig. 5h), indicating that AMPK 
phosphorylation at threonine 172 is not required for AMPK-NBR2 interaction. Together, our 
data revealed that glucose starvation not only induces NBR2 expression, but also enhances 
NBR2 interaction with AMPK, which is likely mediated by NBR2 interaction with the 
kinase domain of AMPK α.
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NBR2 promotes AMPK kinase activity
Next we studied the underlying mechanisms by which NBR2 regulates AMPK function. To 
this end, we first examined whether overexpression of NBR2 exerts any biological effect in 
cells. Our experiments revealed that overexpression of any of the three NBR2 splicing 
isoforms resulted in AMPK activation, mTORC1 inactivation (Fig. 6a, b), and decreased cell 
proliferation without affecting apoptosis under normal culture condition (Fig. 6c). All three 
splicing isoforms of NBR2 share the same first two exons located at the 5’ end of NBR2 
with distinctive exons located toward the 3’ end (Supplemental Fig. 1). Our data thus 
indicate that the common exons in all NBR2 splicing isoforms might be important in 
mediating NBR2 interaction with AMPK. Consistent with this, our binding mapping 
experiments revealed that the first exon shared by all three NBR2 splicing isoforms is both 
required and sufficient to mediate NBR2 interaction with AMPK α (Fig. 6d). Furthermore, 
overexpression of T1 fragment of NBR2 #1, which lacks the first exon (with 159 bp out of 
1045 bp full length NBR2 #1) and thus is incapable of interacting with AMPK, did not 
affect AMPK and mTORC1 activation status or cell proliferation, while in the parallel 
experiments, overexpression of full length (FL) NBR2 #1 exerted the expected effects on 
AMPK signaling (Fig. 6e, f). It seems that overexpression of the first exon alone (T4 
fragment of NBR2 #1) was not sufficient to activate AMPK (Supplemental Fig. 4a), 
suggesting that other regions in NBR2 may be also important for NBR2 function in the 
regulation of AMPK. Together, our results showed that deletion of the first exon of NBR2 
abolishes its interaction with AMPK and regulation of AMPK activation, suggesting that 
NBR2 regulation of AMPK activation and downstream cellular processes is likely mediated 
through NBR2 interaction with AMPK.
Since LKB1 functions as the major upstream kinase of AMPK in response to energy 
stress
13
–
15
, we examined whether NBR2 regulates LKB1 interaction with AMPK. Our 
results showed that NBR2 overexpression or knockdown did not affect AMPK-LKB1 
interaction under either basal or glucose starvation condition (Supplemental Fig. 4b, c). In 
addition, we found that overexpression of NBR2 in Lkb1-deficient Hela cells could still 
promote AMPK activation, and co-expression of NBR2 and LKB1 in Hela cells led to 
synergistic increase of AMPK activation (Supplemental Fig. 4d). Together, our data suggest 
that NBR2 does not regulate AMPK-LKB1 interaction and it is likely that NBR2 operates in 
parallel to LKB1 to regulate AMPK activation.
Our data that NBR2 interacts with the kinase domain of AMPKα (Fig. 5h) prompted the 
hypothesis that NBR2 may directly regulate the kinase activity of the AMPK complex. Our 
data showed that bacterial purified GST-ACC (aa 1–130) could be readily phosphorylated by 
the AMPK complex precipitated from cell lysates of HEK293T cells co-transfected with 
AMPKα/β/γ constructs (Fig. 6g). While in vitro synthesized NBR2 alone did not lead to 
ACC phosphorylation, the addition of NBR2 (but not the T1 fragment of NBR2, the AMPK 
non-binding mutant) to the AMPK complex significantly increased ACC phosphorylation by 
AMPK (Fig. 6g). The in vitro kinase assay using purified AMPKα/β/γ complex and SAMS 
peptide as the AMPK substrate further confirmed that NBR2 promoted AMPK in vitro 
kinase activity (Fig. 6h). Together, our data suggest that NBR2 functions to promote AMPK 
kinase activity likely through its interaction with AMPK kinase domain.
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The functional effects of NBR2 are partially mediated by AMPK
We next sought to determine the extent to which the functional effects of NBR2 are 
mediated by NBR2 regulation of AMPK activation. We first examined whether 
overexpression of NBR2 still exerted its functional effects in AMPKα knockdown cells. 
Such analyses revealed that, while overexpression of NBR2 increased ACC phosphorylation, 
decreased S6 phosphorylation, and suppressed cell proliferation in control siRNA (Ctrl si) 
transfected cells, such effects were attenuated in AMPKα knockdown (AMPK si) cells (Fig. 
7a, b). As a complementary approach, we also examined whether restoration of 
constitutively active (CA) AMPK (1–312 a.a. of AMPK α1) would rescue any of the defects 
observed in NBR2 deficient cells. Our data revealed that overexpression of AMPK CA in 
NBR2 knockdown cells restored ACC or S6 phosphorylation under glucose starvation 
condition as expected (Fig. 7c), and correspondingly, significantly rescued cell proliferation, 
apoptosis, and anchorage independence growth under glucose starvation conditions in NBR2 
deficient cells (Fig. 7d–g). Importantly, restoration of AMPK CA in NBR2 deficient 
background significantly attenuated the enhanced xenograft tumor development caused by 
NBR2 deficiency (Fig. 7h). Taken together, our data strongly suggested that the functional 
effects of NBR2 are at least partially dependent on AMPK.
Discussion
AMPK exists as a heterotrimeric complex comprising of a catalytic α subunit and two 
regulatory β and γ subunits, in which γ subunit directly binds to AMP in response to energy 
stress
31
. It has been proposed that AMP activates AMPK via at least three mechanisms: (i) 
AMP binding to AMPK causes allosteric activation of AMPK; AMP binding leads to 
conformational change of AMPK complex which (ii) promotes Thr172 phosphorylation in 
AMPK α subunit by LKB1 and (iii) inhibits Thr172 de-phosphorylation by protein 
phosphatases31. Our study reveals that lincRNA NBR2 regulation of AMPK represents 
another important regulatory mechanism to control AMPK activation in response to energy 
stress. Here we propose a feed-forward model on NBR2-AMPK regulation. Specifically, 
energy stress-induced initial AMPK activation does not require NBR2. Activated AMPK 
then up-regulates NBR2 expression in response to energy stress. NBR2 in turn interacts with 
AMPK and promotes AMPK kinase activity under energy stress, forming a feed-forward 
loop to potentiate AMPK activation during chronic energy stress conditions (Supplemental 
Fig. 5a). NBR2 deficiency leads to AMPK inactivation during long periods of energy stress, 
which promotes mTORC1 activation, cell proliferation and tumor development 
(Supplemental Fig. 5b). Since transcription regulation in general takes longer time than 
allosteric regulation and phosphorylation events, we reason that cells may have evolved this 
lincRNA-involved regulatory mechanism to maintain AMPK activation during long periods 
of energy stress and to help cells adapt better to chronic stress conditions. In support of this 
model, our time course experiments revealed that NBR2 deficiency compromised AMPK 
activation at later, but not earlier, time points upon glucose starvation (Supplemental Fig. 6a) 
(Note that all the energy stress experiments shown in our studies used 12 hour or longer 
treatment time points). This mirrors well with the kinetics of NBR2 expression induction 
upon glucose starvation (Supplemental Fig. 6b). Since glucose starvation also significantly 
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promotes NBR2 binding to AMPK (Fig. 5), this presumably further amplifies the effect of 
NBR2 to promote AMPK activation.
NBR2 gene was originally identified as a gene which is located near to the breast cancer 
associated gene BRCA1. Both genes lie head to head with each other on human 
chromosome 17, and the physical distance between the transcription start sites of the two 
genes is only 218 bp (Supplemental Fig. 1)27. Given the frequent mutation/deletion rates of 
BRCA1 in human breast and ovarian cancers and the close proximity of NBR2 gene to 
BRCA1 gene, it was initially postulated that NBR2 should be co-deleted/mutated with 
BRCA1 in certain cancers (for example, see32), and NBR2 may also play a role in tumor 
suppression. However, later it became clear that NBR2 does not appear to encode a protein, 
and it was proposed that NBR2 simply is a “junk gene”33. Since then, its potential function 
in tumor biology has remained unknown. In this study, we identified NBR2 as a lincRNA 
induced by energy stress, and showed that NBR2 indeed functions to inhibit tumor 
development, at least in part through its regulation of AMPK activation. It is of note that 
NBR2 overexpression in AMPK deficient cells can still exert moderate cell proliferation 
suppressive effect (Fig. 7b), suggesting that NBR2 may have other AMPK-independent 
function(s) to regulate cell proliferation. Identification and characterization of other NBR2 
binding proteins or RNAs will further clarify its function.
The most popular model proposed for lncRNA function probably is the one that lncRNAs 
regulate gene expression, either in cis or in trans, via recruiting other chromatin-
modification complexes or transcription factors to specific loci34, 35. This raises the 
possibility that NBR2 may regulate the transcription of BRCA1 gene, which resides right 
next to NBR2 gene. However, our data showed that BRCA1 expression was not affected by 
either glucose starvation or NBR2 knockdown (Supplemental Fig. 7). We should mention 
that, although initially it was proposed that lincRNAs mainly function to regulate 
neighboring gene transcription, other studies have shown that many lincRNAs do not exert 
such function1. Whether NBR2 regulates any other gene transcription awaits further 
investigation.
Methods
Cell culture studies
Human kidney cancer cell lines, human breast cancer cell lines, human prostate cancer cell 
lines, human embryonic Kidney 293 cells used in this study were mostly obtained from 
American Type Culture Collection (ATCC). All of the cell lines were free of mycoplasma 
contamination (tested by the vendors using the MycoAlert kit from Lonza). No cell lines 
used in this study are found in the database of commonly misidentified cell lines (ICLAC 
and NCBI Biosample) based on short tandem repeats (STR) profiling performed by vendors. 
Hela or A549 cells with expression of empty vector or Lkb1 expression vectors were 
described in36. siRNA and plasmid transfections were performed using Lipofectamine 3000 
(Life Technologies). Lentiviruses or retroviruses were produced in HEK293T cells with 
packing mix (ViraPower Lentiviral Expression System, Invitrogen) and used to infect target 
cells as per manufacturer's instruction. For glucose starvation experiments, cells were 
cultured in DMEM with different concentrations of glucose (0, 1, or 25 mM) + 10% 
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dialyzed FBS. To measure apoptosis, the cells were stained by Annexin V kit per 
manufacturer instruction (BD Bioscience)37. Briefly, treated cells were washed with PBS 
twice and then 1×106 cells were resuspended in 100µL of 1× binding buffer. FITC-labeled 
Annexin V and propidium iodide were added to samples and incubated in dark for 15 
minutes at room temperature. Subsequently cells were subjected to FACS analysis. Cell 
cycle analysis was carried out as previously reported using FITC BRDU Flow Kit (BD 
Bioscience)38,39. Cell growth and soft agar assays were conducted as described in our 
previous publications40,41. Briefly, for cell growth assay, cells were plated in 24 well plates 
and were determined by crystal violet staining. Cells were stained with 0.1% crystal violet 
(Sigma) solution for 15 min at room temperature. Stained crystal violet was then extracted 
with 10% acetic acid and the intensity of color was measured by photospectormetry at 
OD595. To assess anchorage-independent growth, 10,000 cells per well in 0.4% agarose on 
top of a bottom layer of 0.7% agarose were seed triplicate wells of 6-well plates. Upon the 
formation of colonies, soft agar plates were stained with iodonitrotetrazolium chloride 
(Sigma) and the colonies were counted manually.
Constructs and reagents
shRNAs targeting human NBR2 (NM_005821.2-615s1c1, NM_005821.2-514s1c1) were 
purchased from Sigma (Note that these two shRNAs target splicing isoforms #1 and #3 of 
NBR2, while can still achieve good knockdown efficiency when measured by real time PCR 
primer set designed to detect all three splicing isoforms of NBR2). siRNA targeting AMPKα 
were purchased from Origene (SR303721, SR303722). All three splicing isoforms of NBR2 
were obtained from Thermo Fisher Scientific (MGC human NBR2 sequence-verified 
cDNAs, clone ID: 6452095, 4339497, 4826858) and then were subcloned into Lentiviral 
vector pLVX (Clontech). AMPK α, AMPK β and AMPK γ entry plasmids were obtained 
from Human ORFeome V5.1 library. The entry clones were subsequently recombined into 
gateway-compatible destination expression vectors with Flag tag through LR Gateway 
Technology (Invitrogen). cDNA corresponding to 1–312 a.a. of AMPK α1 was cloned into 
entry vector, and was subsequently recombined into gateway-compatible destination 
expression vectors with V5 tag through LR Gateway Technology (Invitrogen). Active human 
AMPK α2 protein and active human AMPK α1+AMPK β1+AMPK γ1 protein were 
purchase form Abcam (ab79803, ab126916). 2-Deoxy-D-glucose and compound C were 
purchased from Sigma (D6134, P5499). A-769662 was purchased from LC laboratories 
(A-1803).
Quantitative real-time PCR and RIP assay
Total RNA was extracted from cells using RNeasy (Qiagen) and 1st strand cDNA was 
prepared with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, ABI). 
Real-time PCR was performed using QuantiTect SYBR Green PCR kit (Qiagen) or TaqMan 
Universal PCR Master Mix (ABI), and was run on Stratagene MX3000P. For quantification 
of gene expression, the 2−ΔΔCt method was used. GAPDH expression was used for 
normalization. RIP assay was performed with Magna RIP RNA-Binding Protein Immuno-
precipitation Kit (Millipore). Briefly, cells were lysed in RIP lysis buffer. Then the lysates 
were immuno-precipitated with antibody or IgG along with protein magnetic beads. After 
proteinase K digestion, the RNAs pulled down with proteins were purified by phenol 
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chloroform extraction and precipitated in ethanol. The RNAs were then re-suspended in 
RNAse-free water and cDNA was synthesized and subjected to real-time-PCR to detect 
NBR2 or GAPDH (internal control) transcripts. The RNA level was normalized with input 
(10%).
RNA pull-down assays
Biotin labeled RNAs were synthesized by Scientific TranscriptAid T7 High Yield 
Transcription Kit (Thermo). PCR primers with T7 promoters were used to amplify DNA 
templates for RNA synthesis, RNA transcribed in vitro with biotin RNA labelling mix and 
T7 RNA polymerase, treated with RNase-free DNase I (Roche), and purified with the 
RNeasy Mini Kit (Qiagen). Cells lysates or purified proteins were incubated with biotin-
labeled RNAs overnight. The proteins associated with biotin-labeled RNAs were then pulled 
down with Streptavidin Magnetic Beads (Thermo) after 1-hour incubation. The proteins was 
then washed and used for Western blot analysis.
Western blot analysis
Tissues were lysed with RIPA buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 
0.5% Sodium Deoxycholate, 1 mM EDTA, 0.1% SDS) containing complete mini protease 
inhibitors (Roche) and phosphatase inhibitor cocktail (Calbiochem). Cultured cells were 
lysed with NP40 buffer (150 mM sodium chloride, 1.0% NP-40, 50 mM Tris, pH 8.0) 
containing complete mini protease inhibitors (Roche) and phosphatase inhibitor cocktail 
(Calbiochem). Western blots were obtained utilizing 20 to 40 µg of lysate protein. The 
following antibodies were used in this study: anti-FLAG tag (M2) mouse monoclonal 
antibody (Sigma-Aldrich, F3165, 1:5000 dilution), Monoclonal Anti-Vinculin antibody 
(Sigma-Aldrich, V4505, 1:5000 dilution), Phospho-Acetyl-CoA Carboxylase (Ser79) 
Antibody (Cell Signaling Technology, 3661S, 1:1,000 dilution), Acetyl-CoA Carboxylase 
Antibody (Cell Signaling Technology, 3662S, 1:1,000 dilution), Phospho-p70 S6 Kinase 
(Thr389) Antibody (Cell Signaling Technology, 9205S, 1:1,000 dilution), Phospho-AMPKα 
(Thr172) (40H9) Rabbit mAb (Cell Signaling Technology, 2535S, 1:1,000 dilution), 
AMPKα (D63G4) Rabbit mAb (Cell Signaling Technology, 5832S, 1:1,000 dilution), 
AMPKα (F6) Mouse mAb (Cell Signaling Technology, 2793S, 1:1,000 dilution), 
AMPKβ1/2 (57C12) Rabbit mAb (Cell Signaling Technology, 4150S, 1:1,000 dilution) 
AMPKγ1 Antibody (Cell Signaling Technology, 4187S, 1:1,000 dilution), Phospho-Raptor 
(Ser792) Antibody (Cell Signaling Technology, 2083S, 1:1,000 dilution), Raptor (24C12) 
Rabbit mAb (Cell Signaling Technology, 2280S, 1:1,000 dilution), Phospho-S6 Ribosomal 
Protein (Ser240/244) (D68F8) XP® Rabbit mAb (Cell Signaling Technology, 5364S, 
1:5,000 dilution), S6 Ribosomal Protein (5G10) Rabbit mAb (Cell Signaling Technology, 
2217S, 1:5,000 dilution), ULK1 (D8H5) Rabbit mAb (Cell Signaling Technology, 8054 S, 
1:1,000 dilution), Phospho-ULK1 (Ser555) (D1H4) Rabbit mAb (Cell Signaling 
Technology, 5869S, 1:1,000 dilution), Phospho-ULK1 (Ser757) Antibody (Cell Signaling 
Technology, 6888S, 1:1,000 dilution), Cleaved PARP (Asp214) Antibody (Human Specific) 
(Cell Signaling Technology, 9541S, 1:2,000 dilution), PARP Antibody (Cell Signaling 
Technology, 9542S, 1:2,000 dilution), Cleaved Caspase-3 (Asp175) (5A1E) Rabbit mAb 
(Cell Signaling Technology, 9664S, 1:500 dilution), FLCN (D14G9) Rabbit mAb (Cell 
Signaling Technology, 3697S, 1: 2,000 dilution), HSP90 (C45G5) Rabbit mAb #4877 (Cell 
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Signaling Technology, 4877S, 1: 1,000 dilution), GAPDH (D16H11) XP® Rabbit mAb 
(Cell Signaling Technology, 5174S, 1: 5,000 dilution), p70 S6 kinase α Antibody (C-18) 
(Santa Cruz Biotechnology, sc-230, 1:1,000 dilution), SQSTM1 Antibody (H-290) (Santa 
Cruz Biotechnology, sc-52275, 1:2,000 dilution), LKB1 Antibody (E-9) (Santa Cruz 
Biotechnology, sc-374334, 1:2,000 dilution).
Subcellular fractionation
Cells were harvested by trypsin and washed twice with PBS. Cell pellets were lysed in 
buffer I containing 20 mM HEPES, 10 mM KCL, 2 mM MgCl2 and 0.5% NP40. After 
centrifugation, supernatants were collected as cytoplasmic lysis. Pellets were further lysed in 
buffer II containing 0.5 M NaCl, 20 mM HEPES, 10 mM KCL, 2 mM MgCl2 and 0.5% 
NP40. Supernatants were collected as nuclear lysis by centrifugation. Cytoplasmic and 
nuclear fractions were split for RNA extraction and real-time PCR or protein extraction and 
Western blotting. HSP90 and PARP were used as markers of cytoplasm and nucleus in 
Western blotting. GAPDH and U1 were used as markers of cytoplasm and nucleus in real-
time PCR.
Immunofluorescence
Cells were cultured on glass coverslips in six-well plates, washed once with PBS, and fixed 
in 4% paraformaldehyde for 30 min. Coverslips were mounted using Immu-mount (Thermo 
Shandon) and images were captured using Olympus confocal microscope. For quantification 
of autophagic cells, cells with > 10 GFP-LC3 punctuate dots were considered positive. 
Positive cells was counted and expressed as a percentage of total autophagic cells.
AMPK kinase assay
in vitro AMPK kinase activity was assessed using Promega AMPK (A1/B1/G1) Kinase 
Enzyme System (V1921) according to the manufacturer’s instructions. In the kinase assay 
using ACC fragment, bacterial purified GST- ACC 1–130 aa protein was dialyzed against 20 
mM Tris-HCl, pH8.0 and 10% glycerol at 4°C overnight. For AMPK kinase assay, SFB-
AMPKα1, Flag-AMPKβ2 and Flag-AMPKγ1 plasmids were co-transfected into HEK293T 
cells. Cells were lysed 48 hours after transfection. AMPK complex was pulled down by S 
protein beads and subjected to the kinase assay in the presence of 500 µM cold ATP, 10µg in 
vitro synthesized RNAs and 1 µg GST fusion proteins mentioned above. The reaction 
mixture was incubated at 30°C for 30 min, terminated with SDS-loading buffer and 
subjected to SDS-PAGE for Western blot analysis. Phosphorylation of ACC at S79 site was 
determined by ACC S79 phospho-specific antibody.
Xenograft model
All Female athymic Nude-Foxn1nu mice animal (6-week-old) experiments were performed 
in accordance with a protocol approved by the Institutional Animal Care and Use Committee 
of MD Anderson Cancer Center which is in full compliance with policies of the Institutional 
Animal Core and Use Committee (IACUC). Animals arriving in our facility were randomly 
put into cages with five mice each. They were implanted with respective tumor cells in the 
unit of cages, which were randomly selected. MDA-MB-231 cells were counted and 
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suspended at 1.0×107/ml in PBS, approximately one million cells were injected 
subcutaneously into the flank of each mouse with different genotypes, 5 mice per group. 
Tumor volume measurement was initiated at two weeks after injection (defined as starting 
time point: week 0). Tumor progression was then monitored by bi-dimensional tumor 
measurements every five days using a caliper until the endpoint. Mice were sacrificed at the 
endpoint and the tumors were excised for further experiments. The tumor volume was 
calculated according to the equation v = length*width2*1/2. The tumor volume at week n is 
expressed as Relative Tumor Volume (RTV) and calculated according to the following 
formula: RTV = TVn/TV0, where TVn is the tumor volume at week n and TV0 is the tumor 
volume at week 0. The investigators were not blinded to allocation during experiments and 
outcome assessment.
RNA-seq and computational analysis
RNA-seq was performed at Sequencing and Non-Coding RNA Program at the MD 
Anderson Cancer Center using Applied Biosystems SOLiD™ Next Generation Sequencing 
platform. The LifeScope v2.5.1 was used to align the reads to the genome, generate raw 
counts corresponding to each known gene (total 23080 genes, including 4325 non-coding 
genes), and calculate the RPKM (reads per kilobase per million) values. We considered only 
non-coding genes that expressed at relative high levels (RPKM > 2) and showed >2 or < 0.5 
fold changes between control and treatment cells. This identified a list of 17 up-regulated 
and 39 down-regulated non-coding RNAs.
Kaplan Meier survival analysis of cancer patients
We utilized datasets of 4,142 breast tumors which had previously been profiled by 
Affymetrix microarray analysis (www.kmplot.com)42. NBR2 expression (probe set ID: 
207631_at) was divided by the median into high vs. low expression. Survival analysis by 
Kaplan-Meier and Cox Proportional Hazard analysis were performed.
TCGA data analysis
We downloaded the level-3 gene expression data for NBR2 from TCGA pan-cancer project 
Synapse (Synapse ID: syn300013) for breast (BRCA) and kidney cancer (KIRC). We used 
paired student t-test to detect the statistical difference between matched tumor and normal 
samples. We used long-rank tests to detect the overall survival difference between patient 
groups.
Accession numbers
RNA seq datasets (786O cells with or without glucose treatment) have been deposited in the 
Gene Expression Omnibus website with accession code GSE77415. The datasets used in 
Figure.4g were generated from ref.43
Oligonucleotide sequences, probes and primers (forward and reverse)
qPCR primers for gene expression and RIP:
NBR2-Forward: 5’-GGAGGTCTCCAGTTTCGGTA-3’
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NBR2-Reverse: 5’-TTGATGTGTGCTTCCTGGG-3’
(Note that this real time PCR primer set for NBR2 is designed to detect all three 
splicing isoforms of NBR2)
GAPDH-Forward: 5’- CCATGGGGAAGGTGAAGGTC-3’
GAPDH -Reverse: 5’-GAAGGGGTCATTGATGGCAAC-3’
U1-Forward: 5’-TCCCAGGGCGAGGCTTATCCATT-3’
U1-Reverse: 5’-GAACGCAGTCCCCCACTACCACAAAT-3’
BRCA1-Forward: 5’-TGTGCTTTTCAGCTTGACACAGG-3’
BRCA1-Reverse: 5’-CGTCTTTTGAGGTTGTATCCGCTG-3’
Primers for RNA pull down assay:
NBR2#1-Forward: 5’-TAATACGACTCACTATAGGG 
AGGGGTCCAGTTGCGGCTTAT -3’
NBR2#1-Reverse: 5’-AGTTT ACTTA CTATT GCTGA -3’
NBR2#1Anti-sence-Forward: 5’- TAATACGACTCACTATAGGG 
AGTTTACTTACTATT GCTGA -3’
NBR2#1Anti-sence -Reverse: 5’- GGGTCCAGTTGCGGCTTAT -3’
NBR2#2-Forward: 5’- TAATACGACTCACTATAGGG 
GTTGCGGCTTATTGCATCACA-3’
NBR2#2-Reverse: 5’- ACTATTGCTGATTTATTACAAAGGA -3’
NBR2#2Anti-sence-Forward: 5’-TAATACGACTCACTATAGGG 
ACTATTGCTGATTTA TTACAAAGGA -3’
NBR2#2Anti-sence -Reverse: 5’- GTTGCGGCTTATTGCATCACA-3’
NBR2#3-Forward: 5’- TAATACGACTCACTATAGGG 
AGCGGGGTTGCGGCTTATT-3’
NBR2#3-Reverse: 5’- TGGGATTGAGGAGGATCTTT -3’
NBR2#3Anti-sence-Forward: 5’- TAATACGACTCACTATAGGG 
TGGGATTGAGGAGGA TCTTT -3’
NBR2#3Anti-sence -Reverse: 5’- GGGTTGCGGCTTATTGCATC-3’
NBR2#T1-Forward: 5’- TAATACGACTCACTATAGGG 
GTAAAAGTTTTCATTTGATCTG AA-3’
NBR2#T1-Reverse: 5’- AGTTT ACTTA CTATT GCTGA-3’
NBR2#T3-Forward: 5’- TAATACGACTCACTATAGGG 
TTTGCTGAGGATAATGGCCT -3’
NBR2#T3-Reverse: 5’- AGTTT ACTTA CTATT GCTGA-3’
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NBR2#T4-Forward: 5’- TAATACGACTCACTATAGGG 
AGGGGTCCAGTTGCGGCTTAT -3’
NBR2#T4-Reverse: 5’- TTCAGATCAAATGAAAACTTTTAC -3’
NBR2#T5-Forward: 5’- TAATACGACTCACTATAGGG 
AGGGGTCCAGTTGCGGCTTAT -3’
NBR2#T5-Reverse: 5’- CTTCCTGGGCTTCCAGCAC -3’
NBR2#T6-Forward: 5’- TAATACGACTCACTATAGGG 
AGGGGTCCAGTTGCGGCTTAT -3’
NBR2#T6-Reverse: 5’- AGGCCATTATCCTCAGCAAA -3’
Statistics and reproducibility
Most experiments were repeated 3–5 times to be eligible for the indicated statistical 
analyses, and the data exhibited normal distribution. There was no estimation of group 
variation before experiments. For gene expression and RIP assays, relative quantities of gene 
expression level were normalized. The relative quantities of RIP samples were normalized 
by individual inputs, respectively. All results are presented as mean ± the standard deviation 
(SD) of at least three independent experiments, unless otherwise noted. Each exact n values 
are indicated in the corresponding figure legend. Comparisons were performed using two-
tailed paired Student's t-test (*P <0.05, **P <0.01, and ***P <0.001), as indicated in the 
individual figures. For animal studies, five mice per group is the standard sample size for 
tumor xenograft experiments, and no statistical method was used to predetermine sample 
size. None of the samples/animals was excluded from the experiment, and the animals were 
not randomized. The investigators were not blinded to allocation during experiments and 
outcome assessment. For western blotting, representative images are shown. Each of these 
experiments was independently repeated 3–5 times. For survival analysis, the expression of 
NBR2 was treated as a binary variant and divided into `high' and `low' level. Kaplan-Meier 
survival curves were compared using the Gehan-Breslow test with GraphPad Prism 
(GraphPad Software). The experiments were not randomized. The investigators were not 
blinded to allocation during experiments and outcome assessment.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Energy stress induces NBR2 expression through the LKB1-AMPK pathway
(a, b) Various cell lines were cultured in 0 or 25 mM glucose-containing medium (a), or 0 or 
5 mM 2DG-containing medium (b) for 12–24 hours, and then subjected to real-time PCR 
analysis to measure NBR2 expression (Mean ± s.d., n=3 biologically independent extracts, 
two-tailed paired Student’s t-test). (c, d) Hela or A549 cells stably expressing EV (empty 
vector) or Lkb1 expression vectors were cultured in 25 or 0 mM glucose-containing 
medium, and then subjected to real-time PCR (c) (Mean ± s.d., n=3 biologically independent 
extracts, two-tailed paired Student’s t-test) and Western blotting analyses (d). (e) MDA-
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MB-231 cells treated with 100 µM A769662 were subjected to real-time PCR analysis to 
measure NBR2 (Mean ± s.d., n=3 biologically independent extracts, two-tailed paired 
Student’s t-test). (f) MDA-MB-231 cells were treated with 20 µM Compound C in 25 or 0 
mM glucose-containing medium for 24 hours, and then subjected to real-time PCR analysis 
to measure NBR2 expression (Mean ± s.d., n=3 biologically independent extracts, two-tailed 
paired Student’s t-test). (g) MDA-MB-231 cells transfected with AMPKα or control (Ctrl) 
siRNA were cultured in 25 or 0 mM glucose-containing medium for 24 hours, and then 
subjected to real-time PCR analysis to measure NBR2 (Mean ± s.d., n=3 biologically 
independent extracts, two-tailed paired Student’s t-test). Source data for a, b, c, e, f, g can be 
found in Supplementary Table 1. Unprocessed original scans of blots are shown in 
Supplemental Fig. 8.
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Figure 2. NBR2 regulates AMPK-mTORC1 signaling under energy stress
(a) Bar graph showing NBR2 shRNA-mediated knockdown efficiency by real-time PCR 
analysis in 786-O and MDA-MB-231 cells (Mean ± s.d., n=3 biologically independent 
extracts, two-tailed paired Student’s t-test). (b, c) 786-O or MDA-MB-231 cells infected 
with either control shRNA or NBR2 shRNA were cultured in medium with different 
concentrations of glucose for 24 hours. Cell lysates were then analyzed by Western blotting. 
(d) 786-O or MDA-MB-231 cells infected with either control shRNA or NBR2 shRNA were 
cultured in 0 or 5 mM 2DG-containing medium for 12 (for MDA-MB-231 cells) or 16 (for 
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786-O cells) hours. Cell lysates were then analyzed by Western blotting. (e) MDA-MB-231 
cells infected with either control shRNA or NBR2 shRNA were cultured in 0 or 100 µM 
A769662-containing medium for 12 hours. Cell lysates were then analyzed by Western 
blotting. Source data for a can be found in Supplementary Table 1. Unprocessed original 
scans of blots are shown in Supplemental Fig. 8.
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Figure 3. NBR2 regulates cell proliferation, apoptosis, and autophagy in response to energy 
stress
(a) Bar graph showing the percentages of S phase (Brdu positive) cells in control shRNA or 
NBR2 shRNA-infected MDA-MB-231 cells which were cultured in 25 or 0 mM glucose-
containing medium for 24 hours (Mean ± s.d., n=3 biologically independent extracts, two-
tailed paired Student’s t-test). (b, c) Bar graph showing the –Glucose/+Glucose ratio of S 
phase percentages in control shRNA or NBR2 shRNA-infected 786-O cells (b) or MDA-
MB-231 cells (c) (Mean ± s.d., n=3 biologically independent extracts, two-tailed paired 
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Student’s t-test). (d–f) Control shRNA or NBR2 shRNA-infected 786O cells or MDA-
MB-231 cells were cultured in medium with different concentrations of glucose for 24 
hours, then subjected to Annexin V/PI staining followed by FACS analysis to measure the 
percentages of Annexin V positive/PI negative cells (d for 786O cells, e for MDA-MB-231 
cells, Mean ± s.d., n=3 biologically independent extracts, two-tailed paired Student’s t-test), 
or to Western blotting analysis to measure Caspase-3 cleavage (f). (g–h) Bar graph showing 
the percentages of cells with LC3-GFP punctate localization in control shRNA or NBR2 
shRNA-infected 786-O cells (g) or MDA-MB-231 cells (h), which were transfected with 
GFP-LC3 and then cultured in 25 or 0 mM glucose-containing medium for 12 (for MDA-
MB-231 cells) or 18 (for 786-O cells) hours (Mean ± s.d., n=5 fields per group, each field 
was assessed from an independent experiment, two-tailed paired Student’s t-test). (i, j) 786-
O (i) or MDA-MB-231 (j) cells infected with either control shRNA or NBR2 shRNA were 
cultured in glucose free medium for different days as indicated, and then subjected to cell 
proliferation analysis (Mean ± s.d., n=3 biologically independent extracts, two-tailed paired 
Student’s t-test). Source data for a, b, c, d, e, i, j can be found in Supplementary Table 1. 
Unprocessed original scans of blots are shown in Supplemental Fig. 8.
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Figure 4. NBR2 inhibits tumor development
(a, b) 786-O (a) or MDA-MB-231 cells (b) infected with either control shRNA or NBR2 
shRNA were seeded in soft agar containing high or low concentrations of glucose as 
indicated. Bar graph showing the mean colony numbers from the soft agar assay (Mean ± 
s.d., n=5 fields per group, each field was assessed from an independent experiment, two-
tailed paired Student’s t-test). (c) Relative tumor volumes of MDA-MB-231 xenograft 
tumors infected with either control shRNA or NBR2 shRNA at different weeks (Mean ± 
s.e.m., n = 5 xenograft tumors, *: P < 0.05; **: P < 0.01 two-tailed paired Student’s t-test). 
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(d) Protein lysates obtained from xenograft tumors infected with either control shRNA or 
NBR2 shRNA at the end point were subjected to Western blotting analysis as indicated. (e, 
f) The box plot showing the expression pattern of NBR2 for each pair of tumor and normal 
samples in BRCA (e, n=104 matched pairs, Sutdent's t-test and Wilcoxon test) and KIRC (f, 
n=65 matched pairs, Sutdent's t-test and Wilcoxon test). The boxes show the median ±1 
quartile, with whiskers extending to the most extreme data point within 1.5 interquartile 
range from the box boundaries. (g) Kaplan Meier plots of breast cancer patients stratified by 
the expression levels of NBR2 (nhigh = 1767, nlow = 1787, Log-Rank Test). Unprocessed 
original scans of blots are shown in Supplemental Fig. 8.
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Figure 5. Energy stress induces NBR2 interaction with AMPK
(a, b) Nuclear and cytoplasmic fractions of 786O cells were subjected to either real-time 
PCR (a, Mean ± s.d., n=3 biologically independent extracts, two-tailed paired Student’s t-
test) or Western blotting analysis (b). (c) In vitro-synthesized biotinylated sense (S) or 
antisense (AS) NBR2 #1 were incubated with protein lysates from HEK293T cells 
transfected with various vectors as indicated. Precipitation reactions were conducted using 
streptavidin beads and then subjected to Western blotting. (d, f) In vitro-synthesized 
biotinylated sense (S) NBR2 or antisense (AS) NBR2 with different splicing isoforms were 
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incubated with protein lysates from 786-O cells which had been cultured in 25 or 0 mM 
glucose-containing medium for 24 hours. Precipitation reactions were conducted using 
streptavidin beads and then subjected to Western blotting. (e) In vitro-synthesized 
biotinylated sense (S) or antisense (AS) NBR2 #1 were incubated with purified human 
AMPK α protein. Precipitation reactions were conducted using streptavidin beads and then 
subjected to Western blotting. (g) 786-O cells were cultured in 0 or 25 mM glucose-
containing medium for 24 hours. Protein lysates were prepared and immunoprecipitated 
with AMPK α antibody or IgG. The RNA levels of NBR2 in immunoprecipitates or cell 
lysates (input) were measured by real-time PCR (Mean ± s.d., n=3 biologically independent 
extracts, two-tailed paired Student’s t-test). (h) In vitro-synthesized biotinylated NBR2 #1 
were incubated with protein lysates from HEK293T cells transfected with various vectors 
and subjected to glucose starvation. Precipitation reactions were conducted using 
streptavidin beads and then subjected to Western blotting. Source data for a, g can be found 
in Supplementary Table 1. Unprocessed original scans of blots are shown in Supplemental 
Fig. 8.
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Figure 6. NBR2 promotes AMPK kinase activity
(a, b) Protein lysates were prepared from HEK293T (a) or UMRC2 cells (b) with 
overexpression of EV or NBR2 expression vectors, and analyzed by Western blotting. (c) 
UMRC2 cells stably expressing EV or NBR2 expression vectors were cultured in 25 mM 
glucose-containing medium for different days as indicated, and then subjected to cell 
proliferation analysis (Mean ± s.d., n=3 biologically independent extracts, two-tailed paired 
Student’s t-test). (d) Left panel: Schematic diagram showing different truncation mutants of 
NBR2 #1 and the summary of their binding capabilities to AMPK α. Right panel: In vitro-
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synthesized biotinylated sense (S), antisense (AS), or different truncation (T) mutants of 
NBR2 #1 were incubated with protein lysates from 786-O cells which had been cultured in 
glucose free medium for 24 hours. Precipitation reactions were conducted using streptavidin 
beads and then subjected to Western blotting. (e) Protein lysates were prepared from 
HEK293T or UMRC2 cells with overexpression of EV, NBR2 #1 full length (FL), or T1 
mutant expression vectors, and analyzed by Western blotting. (f) UMRC2 cells stably 
expressing EV, NBR2 #1 FL, or T1 mutant expression vectors were cultured in 25 mM 
glucose-containing medium for different days as indicated, and then subjected to cell 
proliferation analysis (Mean ± s.d., n=3 biologically independent extracts, two-tailed paired 
Student’s t-test). (g) AMPK complex precipitated from HEK293T cells was subjected to the 
kinase assay in the presence of ATP, in vitro synthesized RNAs and GST-ACC 1–130 aa 
fusion proteins as indicated. The kinase activity of AMPK was measured by phosphorylation 
of ACC at S79 site. (h) In vitro purified active human AMPK complex was subjected to in 
vitro kinase assays in the presence of ATP, SAMS peptide and in vitro synthesized 
biotinylated sense (S)/antisense (AS)/T1 mutant (T1) NBR2 #1 or several chemical 
compounds (Compound C, A769662, AMP) as indicated (see Materials & Methods for 
details). The Kinase activity was measured by the luminescence with a plate-reading 
illuminometer (Mean ± s.d., n=3 biologically independent extracts, two-tailed paired 
Student’s t-test). Source data for c, f, h can be found in Supplementary Table 1. Unprocessed 
original scans of blots are shown in Supplemental Fig. 8.
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Figure 7. The functional effects of NBR2 are partially mediated by AMPK
(A and B) UMRC2 cells stably expressing EV or NBR2 expression vectors were transfected 
with AMPK siRNA (AMPK si1 or si2) or control siRNA (Ctrl si). Protein lysates were 
prepared and analyzed by Western blotting (a), or cells were cultured in 25 mM glucose-
containing medium for different days as indicated, and then subjected to cell proliferation 
analysis (b) (Mean ± s.d., n=3 biologically independent extracts, two-tailed paired Student’s 
t-test). (c–g) MDA-MB-231 cells with stable expression of control shRNA (Ctrl sh) or 
NBR2 shRNA (NBR2 sh) were infected with empty vector (EV) or constitutively active 
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AMPK (AMPK CA). These cells were cultured in 25 or 0 mM glucose-containing medium 
for 24 hours, and protein lysates were prepared and analyzed by Western blotting (c); The 
cells were cultured in 0 mM glucose-containing medium for different days as indicated, and 
then subjected to crystal violet staining to measure cell number (d) (Mean ± s.d., n=3 
biologically independent extracts, two-tailed paired Student’s t-test); The cells were cultured 
in 25 or 0 mM glucose-containing medium for 24 hours, then subjected to Annexin V/PI 
staining followed by FACS analysis to measure the percentages of Annexin V positive/PI 
negative cells cells (e) (Mean ± s.d., n=5 fields per group, each field was assessed from an 
independent experiment, two-tailed paired Student’s t-test), or to Western blotting analysis 
to measure PARP cleavage (f); The cells were seeded in soft agar containing high or low 
concentrations of glucose as indicated. Bar graph showing the mean colony numbers from 
the soft agar assay (g) (Mean ± s.d., n=5 fields per group, each field was assessed from an 
independent experiment, two-tailed paired Student’s t-test). (h) Relative tumor volumes of 
MDA-MB-231 xenograft tumors of different genotypes at different weeks (Mean ± s.d., n = 
5 xenograft tumors, *: P < 0.05, **: P < 0.01, two-tailed paired Student’s t-test). Source data 
for b, d, e can be found in Supplementary Table 1. Unprocessed original scans of blots are 
shown in Supplemental Fig. 8.
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